Clinical Trial Update: Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating myo-inositol supplementation in women with polycystic ovary syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Myo-inositol (myo-inositol)

Snippet

Sponsor: University Hospital, Lille | Conditions: Polycystic Ovary Syndrome, Reproductive Medicine | Phase 3 | Status: RECRUITING